Varian Medical Systems, Inc. Co (NYSE:VAR).
On July 28 Citigroup kept the stock rating at “Buy” and raised the price expectation to $87.00 from $81.00. January 28 investment analysts at Jefferies made no change to the stock rating of “Buy” and moved down the price target from $90.00 to $85.00.
On January 12, 2016 Barrington Research started coverage with an initial rating of “Outperform” and projecting a price target of $91.00. Equity analyst RBC Capital initiated coverage on the stock setting a rating of “Sector Perform” and a price target of $86.00.
On November 12 analysts at Citigroup initiated coverage with a rating of “Neutral” and setting a price target of $81.00.
In the market the company is trading unchanged by 0.00% since yesterday’s close of $98.81. It is trading at $98.81 just above $95.74, the 50 day moving average and which is just a bit higher than the 200 day moving average of $86.71. The 50 day moving average was up $3.07 or +3.21% whereas the 200 day average was up by +13.95%.
The company’s P/E ratio is 25.08 and the market value is 9.23B. In the latest earnings report the EPS was $3.94 and is projected to be $4.64 for the current year with 93,380,000 shares now outstanding. Next quarter’s EPS is forecasted at $1.10 with next year’s EPS anticipated to be $4.99.